Company intelligence / Profile preview

Daiwa Japan-Taiwan Bio Venture No. 2 Investment

Chiyoda-ku, Tokyo, Japan

Ownership: Private
Development stage: Other

Overview

Daiwa Japan-Taiwan Bio Venture No. 2 Investment is a venture capital fund dedicated to the life sciences, biotechnology, and healthcare sectors in Japan and Taiwan. Managed by Daiwa Corporate Investment, the fund was launched in 2015 to foster cross-border collaboration and industrial development between the two regions. It targets investments in innovative startups specializing in drug discovery, medical technology, and healthcare services. By providing strategic capital and leveraging a broad network of partners, the fund aims to accelerate the growth and global expansion of its portfolio companies.

Industry: Investors

Partnerships

Diamond BioFundDevelopment Bank of Japan

Beyond the preview

Go deeper on Daiwa Japan-Taiwan Bio Venture No. 2 Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daiwa Japan-Taiwan Bio Venture No. 2 Investment.

Explore the full profile